UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000039655 |
|---|---|
| Receipt number | R000045229 |
| Scientific Title | Transverse Testicular Ectopia with Persitent Mullerian Duct Syndrome: An Operative Eureka |
| Date of disclosure of the study information | 2020/06/29 |
| Last modified on | 2020/03/02 04:17:16 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Transverse Testicular Ectopia with Persitent Mullerian Duct Syndrome: An Operative Eureka
Acronym
TTE with PMDS
Scientific Title
Transverse Testicular Ectopia with Persitent Mullerian Duct Syndrome: An Operative Eureka
Scientific Title:Acronym
TTE with PMDS: An Operative Eureka
Region
| Asia(except Japan) |
Condition
Condition
Transverse Testicular Ectopia with Persitent Mullerian Duct Syndrome
Classification by specialty
| Surgery in general | Obstetrics and Gynecology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To perform henioplasty for hernia repair. Toperform orchidectomy of extopic testes to prevent malignacy and to remove abnormal Mullerian derivatives to prevent malignancy.
Basic objectives2
Others
Basic objectives -Others
To perform henioplasty for hernia repair. Toperform orchidectomy of extopic testes to prevent malignacy and to remove abnormal Mullerian derivatives to prevent malignancy.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Ectopic testes and abnormal Mullerian structures were removed. Hernia repair was done and post operatively the patients were healthy.
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male
Key inclusion criteria
Transverse Testicular Ectopia with Persitent Mullerian Duct Syndrome
Key exclusion criteria
Transverse Testicular Ectopia with Persitent Mullerian Duct Syndrome
Target sample size
2
Research contact person
Name of lead principal investigator
| 1st name | Muhammad Umer |
| Middle name | |
| Last name | Mukhtar |
Organization
King Edward Medical University
Division name
Department of Surgery
Zip code
54000
Address
Nila Gumbad Chowk, Anarkali Bazaar Lahore, Punjab 54000
TEL
03324006789
m.umermukhtar@hotmail.com
Public contact
Name of contact person
| 1st name | Muhammad Umer |
| Middle name | |
| Last name | Mukhtar |
Organization
King Edward Medical University
Division name
Department of Surgery
Zip code
54000
Address
Nila Gumbad Chowk, Anarkali Bazaar Lahore, Punjab 54000
TEL
03324006789
Homepage URL
m.umermukhtar@hotmail.com
Sponsor or person
Institute
King Edward Medical University
Institute
Department
Personal name
Funding Source
Organization
King Edward Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
King Edward Medical University
Address
Nila Gumbad Chowk, Anarkali Bazaar Lahore, Punjab 54000
Tel
03324006789
m.umermukhtar@hotmail.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 06 | Month | 29 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
2
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 06 | Month | 29 | Day |
Date of IRB
| 2020 | Year | 03 | Month | 30 | Day |
Anticipated trial start date
| 2020 | Year | 03 | Month | 31 | Day |
Last follow-up date
| 2020 | Year | 04 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2020 | Year | 03 | Month | 02 | Day |
Last modified on
| 2020 | Year | 03 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045229
